CRISPR Therapeutics AG logo

CRISPR Therapeutics AG

NEW
LTS:0VRQ (Switzerland)   Ordinary Shares
$ 50.93 -3.0795 (-5.7%) Jul 13
At Loss
P/B:
2.69
Market Cap:
$ 4.99B
Enterprise V:
$ 3.33B
Volume:
10.99K
Avg Vol (2M):
7.47K
Trade In:
Volume:
10.99K
At Loss
Avg Vol (2M):
7.47K

CRISPR Therapeutics AG (LTS:0VRQ) Dividend

CRISPR Therapeutics AG (LTS:0VRQ) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -6.9%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: LTS:0VRQ Dividend

Does CRISPR Therapeutics AG (LTS:0VRQ) pay a dividend?

CRISPR Therapeutics AG (LTS:0VRQ) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't CRISPR Therapeutics AG pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. CRISPR Therapeutics AG has returned capital to shareholders via buybacks at a rate of -6.9% over the past 3 years.

What are dividend-paying alternatives to CRISPR Therapeutics AG?

For dividend-paying alternatives in CRISPR Therapeutics AG's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.